Virtual Textbook
The simplest Cope rearrangement is the degenerate rearrangement of 1,5-hexatriene. As drawn in the following diagram, this [3.3]-sigmatropic shift may take place by one of two transition states, a lower energy chair state or a higher energy boat state. Because the product is identical with the reactant, isotopic labeling is needed to establish that change has occurred. The relatively high activation energy of this reaction requires a temperature near 300 °C.
If ring strain is relieved in this rearrangement, as in the case of cis-1,2
-divinylcyclopropane, the activation energy is substantially reduced so that conversion to
1,4-cycloheptadiene occurs below 20 °C within 30 minutes, as shown above by
clicking on the diagram. This rearrangement becomes degenerate
for the compound bicyclo[5.1.0]octa-2,7-diene, and the activation energy is further reduced. In
both cases a boat transition state is forced by structural constraint.
If tricyclic analogs are formed by bridging the C1 and C8 carbons of
bicyclo[5.1.0]octa-2,7-diene, similar degenerate rearrangements are observed. Examples will be
displayed above by clicking on the diagram again. For three of
these compounds the activation energy is even lower due to a combination of increased ground
state strain and transition state stabilization by interallylic bonding. The remarkable
C10H10 hydrocarbon bullvalene is exceptional in two respects. First, its
ground state is stabilized relative to the dihydro analog by π-conjugation with the
three-membered ring. Second, its three-fold symmetry permits numerous self-replicating Cope
rearrangements leading to over a million (10!/3=1,209,600) identical valence tautomers. All the
carbons and hydrogens in bullvalene appear to be equivalent on the nmr time scale at 100 °C, and
cannot be discriminated until cooled to -15 °C. Molecules of this kind are termed
fluxional. It is important to recognize that valence tautomerization of this kind is
not resonance (the relative positions of the atoms undergo small changes).
Bullvalene
|
|---|